Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - A new perspective

Histopathology

Volumn 52, Issue 3, 2008, Pages 340-347

  Talaulikar, D ^a,b   Shadbolt, B ^a,b   Bell, J ^a   Khan, K ^a   Dahlstrom, J E ^a,b   McDonald, A ^c   Pidcock, M ^a   Broomfield, A ^a  

^a CANBERRA HOSPITAL   (Australia)

^b The Australian National University   (Australia)

^c National Capital Private Hospital   (Australia)

Author keywords

Bone marrow; Cytology; Diffuse large B cell lymphoma; Flow cytometry; Staging

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW; CANCER STAGING; CANCER SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 38849185182     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02961.x     Document Type: Article

References (19)

1. The Haemato-oncology Task Force of British Committee for Standards in Haematology. BCSH guidelines on nodal non-Hodgkin's lymphoma. Available at: http://www.bcshguidelines.com/pdf/NHL_200504.pdf, 2002. Last accessed 21 January 2008.
2. Miller TP, Dahlberg S, Cassady JR et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N. Engl. J. Med. 1998 339 21 26.
3. Perea G, Altes A, Bellido M et al. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL). Histopathology 2004 45 268 274.
4. Hanson CA, Kurtin PJ, Katzmann JA et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999 94 3889 3896.
5. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin. Cytom. 2003 54 10 18.
6. Gomyo H, Shimoyama M, Minagawa K et al. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma. Haematologica 2003 88 1358 1365.
7. Duggan PR, Easton D, Luider J, Auer IA. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer 2000 88 894 899.
8. Chetty R, Echezarreta G, Comley M, Gatter K. Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma. J. Clin. Pathol. 1995 48 1035 1038.
9. Mitterbauer-Hohendanner G, Mannhalter C, Winkler K et al. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia 2004 18 1102 1107.
10. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J. Clin. Oncol. 1999 17 1244.
11. Marti GE, Rawstron AC, Ghia P et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br. J. Haematol. 2005 130 325 332.
12. Naughton MJ, Hess JL, Zutter MM, Bartlett NL. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test? Cancer 1998 82 1154 1159.
13. Palacio C, Acebedo G, Navarrete M et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Haematologica 2001 86 934 940.
14. Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J. Clin. Pathol. 1990 43 630 632.
15. Pittaluga S, Tierens A, Dodoo YL, Delabie J, De Wolf-Peeters C. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Am. J. Clin. Pathol. 1999 111 179 184.
16. Campbell JK, Matthews JP, Seymour JF, Wolf MM, Juneja SK. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann. Oncol. 2003 14 273 276.
17. Wang J, Weiss LM, Chang KL et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 2002 94 1522 1531.
18. Dunphy C. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. Am. J. Clin. Pathol. 1998 109 625 630.
19. Talaulikar D, Dahlstrom JE, Broomfield A, McNiven M, Shadbolt B. Occult marrow involvement in diffuse large B-cell lymphoma: results of a pilot study. Pathology 2007 39 580 585.